Bioptix Inc news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

BIOP 3.28 +0.08 (2.50%)
price chart
Bioptix, Inc. (NASDAQ:BIOP) Files An 8-K Departure of Directors or Certain ...
On February 7, 2017, Michael Routh resigned from his position as a member of the Board of Directors of Bioptix, Inc.
BRIEF-Bioptix Inc files for mixed shelf offering of up to $20 million - SEC filing
NEW YORK, Feb 16 More Americans fell behind on their car loan payments in the fourth quarter, bringing auto delinquencies to their highest since the height of the financial crisis, Federal Reserve Bank of New York data released on Thursday showed.
BRIEF-Catherine Johanna Defrancesco reports 11.45 pct stake in Bioptix Inc
Feb 7 Arconic Inc. raised questions on Tuesday about the analysis behind Elliott Management's proxy campaign, further escalating the battle between the specialty metals maker and its largest shareholder.
Bioptix Reports Board of Director Changes
BOULDER, Colo., Jan. 6, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP), (the "Company"), announced that Gail Schoettler, Susan Evans and David Welch have resigned from the Company's Board of Directors.
Venaxis Announces Acquisition of BiOptix
13, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced today that it has acquired BiOptix Diagnostics, Inc., ("BiOptix") a Boulder, CO-based privately-held company. BiOptix has developed a proprietary Enhanced Surface Plasmon Resonance ...
Bioptix, Inc. (NASDAQ:BIOP) Files An 8-K Entry into a Material Definitive ...
Bioptix, Inc., formerly Venaxis, Inc., provides Enhanced Surface Plasmon Resonance (SPR) platform for the detection of molecular interactions.
Honig Is Buying Again: This Time, Bioptix Inc. (NASDAQ:BIOP)
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Bioptix Inc. (NASDAQ:BIOP) reported that Honig Barry C. has picked up 504,000 of common stock as of 2017-01-05.
Venaxis Reports Name Change to Bioptix, Inc and NASDAQ Ticker Symbol Change to ...
BOULDER, Colo., Dec. 8, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced that following the approval from shareholders at the 2016 Annual Meeting of Shareholders of the proposal to change the Company's name, the Company's name has ...
Venaxis (APPY) Changes Name to Bioptix; Will Trade Under Ticker 'BIOP'
Bioptix cuts employees, explores 'strategic alternatives'
BOULDER - Bioptix Inc. (Nasdaq: BIOP) announced Friday that it “will terminate certain employees” and will explore strategic alternatives.
Bioptix Announces Streamlining of Workforce (press release)
Colorado biotech cutting employees, exploring 'strategic alternatives'
Shareholder forces out Bioptix board members
BOULDER - A spat between management of Boulder-based Bioptix Inc. (Nasdaq: BIOP) and a Florida shareholder has forced the resignation of three members of the company's board of directors.
Colorado biotech shakes up its board
Barry C. Honig Acquires 4000 Shares of Venaxis, Inc. (BIOP) Stock  Community Financial News